BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther 2020;51:64-77. [PMID: 31701570 DOI: 10.1111/apt.15571] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 22.7] [Reference Citation Analysis]
Number Citing Articles
1 Sousa FIDSE, Medeiros LT, Braga RAM, Daltro AFCS, Maia CSC. Power of mortality prediction in patients awaiting liver transplantation according to the Global Leadership Initiative on Malnutrition criteria and Subjective Global Assessment and Royal Free Hospital Global Assessment scores. Nutrition 2023;106:111889. [PMID: 36525773 DOI: 10.1016/j.nut.2022.111889] [Reference Citation Analysis]
2 Kim TH, Jung YK, Yim HJ. Correspondence on Letter regarding "Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis". Clin Mol Hepatol 2023;29:173-5. [PMID: 36384145 DOI: 10.3350/cmh.2022.0372] [Reference Citation Analysis]
3 Kong M, Lin N, Wang L, Geng N, Xu M, Li S, Song W, Zhou Y, Piao Y, Han Z, Guo R, Yang C, Luo N, Wang Z, Xu Q, Shi D, Qiu W, Li J, Cheung EC, Ma L, Chen Y, Duan Z. Age-specific reference values for low psoas muscle index at the L3 vertebra level in healthy populations: A multicenter study. Front Nutr 2022;9:1033831. [PMID: 36590227 DOI: 10.3389/fnut.2022.1033831] [Reference Citation Analysis]
4 Espina S, Sanz-Paris A, Bernal-Monterde V, Casas-Deza D, Arbonés-Mainar JM. Role of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis. J Clin Med 2022;11. [PMID: 36555953 DOI: 10.3390/jcm11247337] [Reference Citation Analysis]
5 Barbosa FA, Nardelli MJ, Cançado GGL, Silva CF, Osório FMF, Melo RFQ, Taranto DOL, Ferrari TCA, Couto CA, Faria LC. Sarcopenia, body composition and factors associated with variceal gastrointestinal bleeding and splenectomy in hepatosplenic schistosomiasis mansoni. Trans R Soc Trop Med Hyg 2022;116:1145-53. [PMID: 35748511 DOI: 10.1093/trstmh/trac052] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Sinn DH, Kang D, Kang M, Guallar E, Hong YS, Lee KH, Park J, Cho J, Gwak GY. Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study. Hepatology 2022;76:1746-54. [PMID: 35588190 DOI: 10.1002/hep.32578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Hou W, Wu J, Wang K, Wang Z, Wang Z, Chen F, Yu H, Meng Q. Sarcopenia is associated with reduced 5-year survival in cirrhotic patients with age ≥ 65 and Child-Pugh score ≥ 7.. [DOI: 10.21203/rs.3.rs-2251805/v1] [Reference Citation Analysis]
8 Bahari H, Aliakbarian M, Norouzy A, Shadnoush M, Akhavan-rezayat K, Esfehani AJ, Nematy M. Comparison of Nutritional Risk Index with Subjective Global Assessment in evaluating the nutritional status of liver transplant candidates.. [DOI: 10.21203/rs.3.rs-2315960/v1] [Reference Citation Analysis]
9 Zhang L, Fang X, Wang S, Ma S, Zhang J, Dong X, Dai J, Liu C, Gao Y. Integrated Analysis of mRNA and lncRNA Expression Profiles Reveals Regulatory Networks Associated with Decompensated Cirrhosis. Journal of Immunology Research 2022;2022:1-13. [DOI: 10.1155/2022/1805216] [Reference Citation Analysis]
10 Meister FA, Verhoeven S, Mantas A, Liu WJ, Jiang D, Heij L, Heise D, Bruners P, Lang SA, Ulmer TF, Neumann UP, Bednarsch J, Czigany Z. Osteopenia is associated with inferior survival in patients undergoing partial hepatectomy for hepatocellular carcinoma. Sci Rep 2022;12:18316. [PMID: 36316524 DOI: 10.1038/s41598-022-21652-z] [Reference Citation Analysis]
11 Jamali T, Raasikh T, Bustamante G, Sisson A, Tandon P, Duarte-Rojo A, Hernaez R. Outcomes of Exercise Interventions in Patients With Advanced Liver Disease: A Systematic Review of Randomized Clinical Trials. Am J Gastroenterol 2022;117:1614-20. [PMID: 35973182 DOI: 10.14309/ajg.0000000000001883] [Reference Citation Analysis]
12 Noda T, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Yamashita M, Uchida S, Maekawa E, Terada T, Reed JL, Yamaoka-Tojo M, Matsunaga A, Ako J. Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure. J Cardiol 2022:S0914-5087(22)00223-4. [PMID: 36167755 DOI: 10.1016/j.jjcc.2022.08.015] [Reference Citation Analysis]
13 Mahmud N, Goldberg DS, Abu-Gazala S, Lewis JD, Kaplan DE. Modeling Optimal Clinical Thresholds for Elective Abdominal Hernia Repair in Patients With Cirrhosis. JAMA Netw Open 2022;5:e2231601. [PMID: 36098965 DOI: 10.1001/jamanetworkopen.2022.31601] [Reference Citation Analysis]
14 Guarino M, Cossiga V, Becchetti C, Invernizzi F, Lapenna L, Lavezzo B, Lenci I, Merli M, Pasulo L, Zanetto A, Burra P, Morisco F; Special Interest Group Gender in Hepatology of the Italian Association for the Study of the Liver (AISF). Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature. Dig Liver Dis 2022;54:997-1006. [PMID: 34789397 DOI: 10.1016/j.dld.2021.10.010] [Reference Citation Analysis]
15 van Dijk AM, Coppens BJP, van Beers MA, Bruins Slot AS, Verstraete CJR, de Bruijne J, Vleggaar FP, van Erpecum KJ. Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome. Eur J Intern Med 2022:S0953-6205(22)00250-3. [PMID: 35902333 DOI: 10.1016/j.ejim.2022.07.002] [Reference Citation Analysis]
16 Wu YK, Li M, Zhang YC, Gao RZ, Su Y, Zhou Y, Zhao KL, Chen C, Wang WX. The sarcopenia index is an effective predictor for malnutrition in patients with liver cirrhosis. Nutr Diet 2022. [PMID: 35434892 DOI: 10.1111/1747-0080.12738] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Adler M, Millar EC, Deans KA, Torreggiani M, Moroni F. Dietary Management of Chronic Kidney Disease and Secondary Hyperoxaluria in Patients with Short Bowel Syndrome and Type 3 Intestinal Failure. Nutrients 2022;14:1646. [PMID: 35458207 DOI: 10.3390/nu14081646] [Reference Citation Analysis]
18 Kim SJ, Chun IA, Cho JY, Lee JH, Lee J, Kim YD, Park CG. ω-3 fatty acid-enriched parenteral nutrition shortens hospital stay in acute variceal bleeding cirrhotic patients. Medicine (Baltimore) 2022;101:e29128. [PMID: 35446295 DOI: 10.1097/MD.0000000000029128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Li C, Zhao C, Yu Z, Yang W, Sun M, Li Y, Guo G, Hui Y, Wang X, Fan X, Wang B, Zhang J, Sun C. Low free triiodothyronine levels are associated with frail phenotype in hospitalized inpatients with cirrhosis. Postgrad Med 2022. [PMID: 35382681 DOI: 10.1080/00325481.2022.2063487] [Reference Citation Analysis]
20 Topan M, Sporea I, Dănilă M, Popescu A, Ghiuchici A, Lupușoru R, Șirli R. Comparison of Different Nutritional Assessment Tools in Detecting Malnutrition and Sarcopenia among Cirrhotic Patients. Diagnostics 2022;12:893. [DOI: 10.3390/diagnostics12040893] [Reference Citation Analysis]
21 Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH. Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis. J Hepatol 2022;76:588-99. [PMID: 34785325 DOI: 10.1016/j.jhep.2021.11.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 27.0] [Reference Citation Analysis]
22 Iacob S, Mina V, Mandea M, Iacob R, Vadan R, Boar V, Ionescu G, Buzescu D, Gheorghe C, Gheorghe L. Assessment of Sarcopenia Related Quality of Life Using SarQoL® Questionnaire in Patients With Liver Cirrhosis. Front Nutr 2022;9:774044. [DOI: 10.3389/fnut.2022.774044] [Reference Citation Analysis]
23 Xiao Y, Xiao-Yue Z, Yue W, Ruo-Tao L, Xiang-Jie L, Xing-Yuan W, Qian W, Xiao-Hua Q, Zhen-Yi J. Use of computed tomography for the diagnosis of surgical sarcopenia: Review of recent research advances. Nutr Clin Pract 2022. [PMID: 35191086 DOI: 10.1002/ncp.10847] [Reference Citation Analysis]
24 Meister FA, Lurje G, Verhoeven S, Wiltberger G, Heij L, Liu WJ, Jiang D, Bruners P, Lang SA, Ulmer TF, Neumann UP, Bednarsch J, Czigany Z. The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort. Cancers (Basel) 2022;14:720. [PMID: 35158988 DOI: 10.3390/cancers14030720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
25 Tobberup R, Jager-Wittenaar H, Sørensen J, Kopp LHP, Svarstad P, Sætre P, Ottery FD. Translation and cultural adaptation of the scored Patient-Generated Subjective Global Assessment (PG-SGA©). Clin Nutr ESPEN 2022;47:215-20. [PMID: 35063204 DOI: 10.1016/j.clnesp.2021.12.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zambon Azevedo V, Silaghi CA, Maurel T, Silaghi H, Ratziu V, Pais R. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Front Nutr 2022;8:774030. [DOI: 10.3389/fnut.2021.774030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Gougol A, Behari J. Biomarkers of Malnutrition in Cirrhosis. Biomarkers in Disease: Methods, Discoveries and Applications 2022. [DOI: 10.1007/978-3-031-07389-2_43] [Reference Citation Analysis]
28 Ayares G, Idalsoaga F, Díaz LA, Arnold J, Arab JP. Current Medical Treatment for Alcohol-Associated Liver Disease. J Clin Exp Hepatol 2022;12:1333-48. [PMID: 36157148 DOI: 10.1016/j.jceh.2022.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Wang S, Tandon P. The Impact of Sarcopenia, Frailty, and Malnutrition on Further Decompensation. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_50] [Reference Citation Analysis]
30 Gougol A, Behari J. Biomarkers of Malnutrition in Cirrhosis. Biomarkers in Disease: Methods, Discoveries and Applications 2022. [DOI: 10.1007/978-3-030-81304-8_43-1] [Reference Citation Analysis]
31 D'Amico G, Bernardi M, Angeli P. Towards a new definition of decompensated cirrhosis. J Hepatol 2022;76:202-7. [PMID: 34157322 DOI: 10.1016/j.jhep.2021.06.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
32 Bergasa NV. Complications of Liver Disease. Clinical Cases in Hepatology 2022. [DOI: 10.1007/978-1-4471-4715-2_15] [Reference Citation Analysis]
33 Koh FH, Loh CH, Tan WJ, Ho LML, Yen D, Chua JMW, Kok SSX, Sivarajah SS, Chew MH, Foo FJ. Structured presurgery prehabilitation for aged patients undergoing elective surgery significantly improves surgical outcomes and reduces cost: A nonrandomized sequential comparative prospective cohort study. Nutr Clin Pract 2021. [PMID: 34861063 DOI: 10.1002/ncp.10787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Pimentel CFMG, Amaral ACC, Gonzalez AM, Lai M, Mota DO, Ferraz MLG, Junior WM, Kondo M. Six-minute walking test performance is associated with survival in cirrhotic patients. World J Hepatol 2021; 13(11): 1791-1801 [PMID: 34904046 DOI: 10.4254/wjh.v13.i11.1791] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Yang W, Wang X, Yu Z, Li C, Sun M, Li Y, Hui Y, Guo G, Fan X, Jiang K, Sun C. Low Levels of Serum Zinc Associate with Malnutrition Risk Assessed by the Royal Free Hospital-Nutritional Prioritizing Tool in Cirrhosis. Biol Trace Elem Res 2021. [PMID: 34791623 DOI: 10.1007/s12011-021-03033-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Topan MM, Sporea I, Dănilă M, Popescu A, Ghiuchici AM, Lupuşoru R, Şirli R. Impact of Sarcopenia on Survival and Clinical Outcomes in Patients With Liver Cirrhosis. Front Nutr 2021;8:766451. [PMID: 34746216 DOI: 10.3389/fnut.2021.766451] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Siramolpiwat S, Kiattikunrat K, Soontararatpong R, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Bhanthumkomol P, Nunanun P, Issariyakulkarn N. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis. Scand J Gastroenterol 2021;56:1210-9. [PMID: 34338110 DOI: 10.1080/00365521.2021.1957497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
38 Bunchorntavakul C, Reddy KR. Letter: patients who have both sarcopenia and frailty have similar prognosis to those with either condition separately-authors' reply. Aliment Pharmacol Ther 2021;54:983-4. [PMID: 34506657 DOI: 10.1111/apt.16581] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Alexopoulos T, Vasilieva L, Kontogianni MD, Mani I, Alexopoulou A. Letter: patients who have both sarcopenia and frailty have similar prognosis to those with either condition separately. Aliment Pharmacol Ther 2021;54:981-2. [PMID: 34506659 DOI: 10.1111/apt.16564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Lin FP, Visina JM, Bloomer PM, Dunn MA, Josbeno DA, Zhang X, Clemente-Sanchez A, Tevar AD, Hughes CB, Jakicic JM, Duarte-Rojo A. Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease. Am J Gastroenterol 2021;116:2105-17. [PMID: 34313620 DOI: 10.14309/ajg.0000000000001376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
41 Zeng X, Shi ZW, Yu JJ, Wang LF, Luo YY, Jin SM, Zhang LY, Tan W, Shi PM, Yu H, Zhang CQ, Xie WF. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle 2021;12:1948-58. [PMID: 34520115 DOI: 10.1002/jcsm.12797] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
42 Boster JM, Saiman Y. Nutritional Management of Sarcopenia in Chronic Liver Disease. Curr Treat Options Gastro 2021;19:509-523. [DOI: 10.1007/s11938-021-00356-9] [Reference Citation Analysis]
43 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 39.5] [Reference Citation Analysis]
44 Boursier J, Anty R, Carette C, Cariou B, Castera L, Caussy C, Fontaine H, Garioud A, Gourdy P, Guerci B, Guillaume M, Michot N, Minello A, Ouizeman DJ, Serfaty L, Bonnet F, Vergès B, Petit JM; AFEF and SFD. Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement. Diabetes Metab 2021;47:101272. [PMID: 34363981 DOI: 10.1016/j.diabet.2021.101272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Casas Deza D, Betoré Glaria ME, Sanz-París A, Lafuente Blasco M, Fernández Bonilla EM, Bernal Monterde V, Arbonés-Mainar JM, Fuentes Olmo J. Response to "Malnutrition in patients with cirrhosis: Screen or treat?". Nutr Clin Pract 2021. [PMID: 34339062 DOI: 10.1002/ncp.10748] [Reference Citation Analysis]
46 Nishikawa H, Yoh K, Enomoto H, Nishiguchi S, Iijima H. Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases. Diagnostics (Basel) 2021;11:1262. [PMID: 34359344 DOI: 10.3390/diagnostics11071262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Nishikawa H, Yoh K, Enomoto H, Nishimura T, Nishiguchi S, Iijima H. Factors Associated With Longitudinal QOL Change in Patients With Chronic Liver Diseases. In Vivo 2021;35:2451-6. [PMID: 34182530 DOI: 10.21873/invivo.12524] [Reference Citation Analysis]
48 Nishikawa H, Yoh K, Enomoto H, Ikeda N, Takashima T, Aizawa N, Nishimura T, Nishiguchi S, Iijima H. Predictors for Grip Strength Loss in Patients With Chronic Liver Diseases. In Vivo 2021;35:363-71. [PMID: 33402485 DOI: 10.21873/invivo.12267] [Reference Citation Analysis]
49 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points. In Vivo 2020;34:2549-59. [PMID: 32871784 DOI: 10.21873/invivo.12072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases. In Vivo. 2020;34:2561-2569. [PMID: 32871785 DOI: 10.21873/invivo.12073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Wang X, Feng H, Hui Y, Zhao T, Mao L, Fan X, Cui B, Lin L, Zhang J, Wang B, Yu Q, Zhao X, Sun C. A predictive nomogram incorporating gait speed for all-cause mortality in hospitalized cirrhotics. Postgrad Med 2021;133:680-7. [PMID: 34029498 DOI: 10.1080/00325481.2021.1934494] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Ponziani FR, Picca A, Marzetti E, Calvani R, Conta G, Del Chierico F, Capuani G, Faccia M, Fianchi F, Funaro B, Josè Coelho-Junior H, Petito V, Rinninella E, Paroni Sterbini F, Reddel S, Vernocchi P, Cristina Mele M, Miccheli A, Putignani L, Sanguinetti M, Pompili M, Gasbarrini A; GuLiver study group. Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia. Liver Int 2021;41:1320-34. [PMID: 33713524 DOI: 10.1111/liv.14876] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
53 Vidot H, Shackel NA. Nutritional Supplementation for Patients with Decompensated Cirrhosis. Curr Hepatology Rep 2021;20:53-60. [DOI: 10.1007/s11901-021-00561-1] [Reference Citation Analysis]
54 Lefere S, Onghena L, Vanlander A, van Nieuwenhove Y, Devisscher L, Geerts A. Bariatric surgery and the liver-Mechanisms, benefits, and risks. Obes Rev 2021;22:e13294. [PMID: 34002452 DOI: 10.1111/obr.13294] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
55 Cañamares-Orbis P, Bernal-Monterde V, Sierra-Gabarda O, Casas-Deza D, Garcia-Rayado G, Cortes L, Lué A. Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 2021;13:1650. [PMID: 34068295 DOI: 10.3390/nu13051650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Nishikawa H, Yoh K, Enomoto H, Nishimura T, Nishiguchi S, Iijima H. Clinical impact of the finger-circle test in patients with liver diseases. Hepatol Res 2021;51:603-13. [PMID: 33772972 DOI: 10.1111/hepr.13639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Casas Deza D, Betoré Glaria ME, Sanz-París A, Lafuente Blasco M, Fernández Bonilla EM, Bernal Monterde V, Arbonés Mainar JM, Fuentes Olmo J. Mini Nutritional Assessment - Short Form Is a Useful Malnutrition Screening Tool in Patients with Liver Cirrhosis, Using the Global Leadership Initiative for Malnutrition Criteria as the Gold Standard. Nutr Clin Pract 2021;36:1003-10. [PMID: 33817839 DOI: 10.1002/ncp.10640] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
58 Nishikawa H, Yoh K, Enomoto H, Nishimura T, Nishiguchi S, Iijima H. Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study. Ann Transl Med 2021;9:624. [PMID: 33987322 DOI: 10.21037/atm-20-6901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
59 Kishino K, Enomoto H, Shimono Y, Moriwaki EI, Nishikawa H, Nishimura T, Iwata Y, Iijima H, Nishiguchi S. Association of an Overhydrated State With the Liver Fibrosis and Prognosis of Cirrhotic Patients. In Vivo 2020;34:1347-53. [PMID: 32354929 DOI: 10.21873/invivo.11912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
60 Noda T, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Nakamura T, Yamashita M, Uchida S, Maekawa E, Reed JL, Yamaoka-Tojo M, Matsunaga A, Ako J. Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure. Sci Rep 2021;11:3715. [PMID: 33580115 DOI: 10.1038/s41598-020-80641-2] [Reference Citation Analysis]
61 Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in Patients with Liver Cirrhosis. Nutrients 2021;13:540. [PMID: 33562292 DOI: 10.3390/nu13020540] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
62 Kardashian A, Wilder J, Terrault NA, Price JC. Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action. Hepatology 2021;73:811-20. [PMID: 33150599 DOI: 10.1002/hep.31605] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
63 Saiman Y, Serper M. Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant. Clin Liver Dis 2021;25:35-51. [PMID: 33978582 DOI: 10.1016/j.cld.2020.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Bhanji RA, Saiman Y, Watt KD. Nonalcoholic Steatohepatitis, Sarcopenia, and Liver Transplantation. Clin Liver Dis (Hoboken) 2021;17:2-5. [PMID: 33552477 DOI: 10.1002/cld.1000] [Reference Citation Analysis]
65 Tribus L, Sfeatcu R. Muscle wasting in advanced liver disease: from pathogenesis to therapeutic interventions. Medic ro 2021;3:16. [DOI: 10.26416/med.141.3.2021.4979] [Reference Citation Analysis]
66 Badran H, Elsabaawy MM, Ragab A, Aly RA, Alsebaey A, Sabry A. Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients. Asian Pac J Cancer Prev 2020;21:3285-90. [PMID: 33247686 DOI: 10.31557/APJCP.2020.21.11.3285] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
67 Altajar S, Baffy G. Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol 2020;8:414-23. [PMID: 33447525 DOI: 10.14218/JCTH.2020.00065] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
68 Meyer F, Bannert K, Wiese M, Esau S, Sautter LF, Ehlers L, Aghdassi AA, Metges CC, Garbe LA, Jaster R, Lerch MM, Lamprecht G, Valentini L. Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis. Int J Mol Sci 2020;21:E5357. [PMID: 32731496 DOI: 10.3390/ijms21155357] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
69 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. Int J Mol Sci. 2020;21:5254. [PMID: 32722100 DOI: 10.3390/ijms21155254] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
70 Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2020;52:311-8. [PMID: 32537744 DOI: 10.1111/apt.15821] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
71 Nishikawa H, Yoh K, Enomoto H, Ikeda N, Aizawa N, Koriyama T, Nishimura T, Nishiguchi S, Iijima H. Anthropometric Measurements and Frailty in Patients with Liver Diseases. Diagnostics (Basel). 2020;10:433. [PMID: 32630551 DOI: 10.3390/diagnostics10060433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
72 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Health-Related Quality of Life and Frailty in Chronic Liver Diseases. Life (Basel) 2020;10:E76. [PMID: 32456292 DOI: 10.3390/life10050076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
73 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Serum Zinc Level Is Associated with Frailty in Chronic Liver Diseases. J Clin Med 2020;9:E1570. [PMID: 32455875 DOI: 10.3390/jcm9051570] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
74 Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ikeda N, Aizawa N, Nishimura T, Iijima H, Nishiguchi S. Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases. Diagnostics (Basel) 2020;10:E238. [PMID: 32325995 DOI: 10.3390/diagnostics10040238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
75 Vidot H, Kline K, Cheng R, Finegan L, Lin A, Kempler E, Strasser SI, Bowen DG, McCaughan GW, Carey S, Allman-Farinelli M, Shackel NA. Reply to "Comments on the Editor Re: The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097.". Nutrients 2020;12:E869. [PMID: 32213917 DOI: 10.3390/nu12030869] [Reference Citation Analysis]